Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases

BACKGROUND: Activation of the type I interferon (IFN) response program is described for several autoimmune diseases, including systemic lupus erythematosus (SLE), multiple sclerosis (MS), myositis (IIM) and rheumatoid arthritis (RA). While IFNα contributes to SLE pathology, IFNβ therapy is often ben...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: de Jong, Tamarah D., Vosslamber, Saskia, Mantel, Elise, de Ridder, Sander, Wesseling, John G., van der Pouw Kraan, Tineke C. T. M., Leurs, Cyra, Hegen, Harald, Deisenhammer, Florian, Killestein, Joep, Lundberg, Ingrid E., Vencovsky, Jiri, Nurmohamed, Mike T., van Schaardenburg, Dirkjan, Bultink, Irene E. M., Voskuyl, Alexandre E., Pegtel, D. Michiel, van der Laken, Conny J., Bijlsma, Johannes W. J., Verweij, Cornelis L.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4756531/
https://ncbi.nlm.nih.gov/pubmed/26882897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0946-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados